Ibogaine by David Dardashti marks 16 years in addiction treatment

Ibogaine by David Dardashti marks 16 years in addiction treatment

Ibogaine by David Dardashti, based in Playa del Carmen, Mexico, has announced a reaffirmation of its mission after 16 years of providing specialized addiction recovery services. The center is known for its distinctive approach to ibogaine treatment, which emphasizes precision dosing and comprehensive care, according to a recent announcement.

What the center offers

The facility, led by founder David Dardashti, focuses on using ibogaine to provide patients with a clear cognitive perspective on their life experiences and trauma. Unlike other psychedelics like LSD and psilocybin, which often lead to perceptual distortions, ibogaine is said to facilitate an introspective review of life events, helping individuals confront the root causes of addiction.

Key treatment protocols

Dardashti outlines several core clinical pillars that define the treatment programs at the facility. These include optimized treatment windows of 6 to 9 hours to minimize physical exhaustion, the use of pure ibogaine hydrochloride for precise dosing, and the avoidance of replacement opioids for withdrawal management. Instead, the clinic uses ibogaine micro-boosters to alleviate withdrawal symptoms.

Institutional oversight and data management

To ensure clinical precision, Dania Oliver has been appointed as Executive Assistant, responsible for overseeing protocol compliance and managing the systematic archiving of patient data. This rigorous documentation process is intended to enhance the safety and efficacy of treatments.

Why it matters

The center's approach to ibogaine treatment is significant in the context of ongoing research into alternative therapies for addiction. By focusing on precision and comprehensive care, the facility aims to offer a viable option for individuals seeking to overcome substance dependence and related issues.

Ibogaine by David Dardashti continues to refine its methodologies, contributing to the broader understanding of ibogaine's potential in addiction treatment.